ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

UT Health System’s Probe Finds Lapses at MD Anderson, CPRIT—But No Nepotism

June 15, 2012

Women’s Health Trial Not Dead; Pls Say They’ll Improve Protocol, Make New Plans For Full Implementation

January 29, 1988

Brigid Levental, Pediatric researcher, Dead At 58

February 18, 1994

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989

Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators

May 3, 1974